共 50 条
- [31] Secukinumab provides sustained improvements in dermatology-specific quality of life in moderate to severe psoriasis patients through 3 years of treatment: Results from the SCULPTURE extension studyJOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB232 - AB232Bissonnette, RobertLuger, ThomasThaci, DiamantToth, DarrylMessina, IzabellaBhosekar, VaishaliGilloteau, IsabellePapavasillis, Charis
- [32] Secukinumab Improves Patient Perception of Anxiety and Depression in Patients with Moderate to Severe Psoriasis: A Post hoc Analysis of the SUPREME StudyACTA DERMATO-VENEREOLOGICA, 2021, 101Talamonti, MarinaMalara, GiovannaNatalini, YleniaBardazzi, FedericoConti, AndreaChiricozzi, AndreaMugheddu, CristinaGisondi, PaoloPiaserico, StefanoPagnanelli, GianlucaAmerio, PaoloPotenza, ConcettaCantoresi, FrancaFargnoli, Maria ConcettaBalato, AnnaLoconsole, FrancescoOffidani, AnnamariaBonifati, ClaudioPrignano, FrancescaBartezaghi, MartaRausa, AliceAloisi, ElisabettaOrsenigo, RobertoCostanzo, Antonio
- [33] Evaluation of Infections With Secukinumab in a Pooled Analysis of 10 Clinical Studies of Moderate-to-Severe Plaque PsoriasisJOURNAL OF INVESTIGATIVE DERMATOLOGY, 2014, 134 : S33 - S33Tsai, T.Blauvelt, A.Karpov, A.Huang, J.Cooper, S.Fox, T.
- [34] In which patients the best efficacy of secukinumab? Update of a real-life analysis after 136 weeks of treatment with secukinumab in moderate-to-severe plaque psoriasisEXPERT OPINION ON BIOLOGICAL THERAPY, 2020, 20 (02) : 173 - 182Galluzzo, MarcoD'Adamio, SimoneSilvaggio, DionisioLombardo, PaoloBianchi, LucaTalamonti, Marina
- [35] Secukinumab Treatment of moderate to severe Plaque Psoriasis in the clinical Routine Care: Baseline Data from the PROSPECT Study on Psoriasis Pre-treatmentJOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2017, 15 : 138 - 138von Kiedrowski, R.Korber, A.Kraehn-Senftleben, G.Sticherling, M.Lange, L.Bachhuber, T.Kasparek, T. R.Augustin, M.Thaci, D.Amon, U.
- [36] Secukinumab sustainability of response in subjects with moderate to severe plaque psoriasis: A subanalysis from the FIXTURE studyJOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 70 (05) : AB188 - AB188Reich, KristianPapavassilis, CharisPuig, LuisNotter, MarianneDraelos, Zoe
- [37] Secukinumab is effective in treatment of moderate-to-severe plaque psoriasis: real-life effectiveness and safety from the PROSPECT studyJOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2020, 34 (02) : 310 - 318Thaci, D.Koerber, A.von Kiedrowski, R.Bachhuber, T.Melzer, N.Kasparek, T.Duetting, E.Kraehn-Senftleben, G.Amon, U.Augustin, M.
- [38] Efficacy and safety of secukinumab in Taiwanese patients with moderate to severe plaque psoriasis: Subanalysis from ERASURE phase III studyJOURNAL OF DERMATOLOGY, 2017, 44 (10): : 1129 - 1137Wu, Nan-LinHsu, Chih-JungSun, Fang-JuTsai, Tsen-Fang
- [39] Efficacy of guselkumab versus secukinumab in subpopulations of patients with moderate-to-severe plaque psoriasis: results from the ECLIPSE studyJOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (04) : 2317 - 2324Blauvelt, AndrewArmstrong, April W.Langley, Richard G.Gebauer, KurtThaci, DiamantBagel, JerryGuenther, Lyn C.Paul, CarleRandazzo, BruceFlavin, SusanHsu, Ming-ChunYou, YinReich, Kristian
- [40] Efficacy of secukinumab and adalimumab in psoriatic arthritis patients with moderate-to-severe plaque psoriasis: Results from the EXCEED studyJOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB92 - AB92Gottlieb, Alice B.Merola, Joseph F.Reich, KristianBehrens, FrankNash, PeterBao, WeibinPellet, PascalePricop, LuminitaMcInnes, Iain B.